A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer

Conditions:   Small Cell Lung Carcinoma (SCLC);   Neuroendocrine Neoplasms Interventions:   Drug: BI 764532;   Drug: [89Zr]Zr-BI 764532 Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials